IV drips, commonly used in hospitals for medical purposes, have become increasingly popular in wellness spas. These spas promote expensive IV cocktails claiming to enhance immunity, alleviate hangovers, and mitigate chemotherapy side effects. Despite these claims, medical experts caution that many clinics lack evidence to support their promises and pose potential health risks.
The medical spa industry, which includes IV hydration clinics, has seen significant growth in the U.S. and Canada. The number of these facilities has risen sharply, with prices often exceeding $200 for personalized supplement cocktails containing electrolytes, magnesium, and various vitamins. Despite the proliferation of these clinics, there is a lack of regulatory oversight in both countries.
A recent study published in JAMA Internal Medicine highlighted the varying state-level policies and practices regulating IV spas in the U.S. The absence of a unified regulatory body leaves consumers vulnerable to potential harm. In Canada, the regulatory landscape is similarly complex, with different bodies overseeing aspects like IV drip contents, medical professionals involved, and clinic safety.
While Health Canada regulates IV health products as drugs, the customization of mixtures poses challenges in ensuring safety. Various provincial regulatory bodies oversee different medical professions, but gaps in oversight persist. Complaints about unsafe practices and unauthorized substances have led to scrutiny of IV clinics, with concerns about potential harm to clients.
Despite claims of mitigated risks through proper regulation, critics argue that the broad health claims made by IV spas lack scientific backing. The necessity of basic IV hydration outside medical emergencies is questioned, with experts advocating for traditional hydration methods over costly IV treatments for common ailments like hangovers or headaches.
